This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Katzav, S Articles by Pulido, D Search for Related Content PubMed PubMed Citation Articles by Katzav, S Articles by Pulido, D

Loss of the amino-terminal helix-loop-helix domain of the vav proto-oncogene activates its transforming potential.

Department of Biochemistry, St. Jude Children's Research Hospital, Memphis, Tennessee 38105.

ABSTRACT

vav, a novel human oncogene, was originally generated in vitro by replacement of its normal 5' coding sequences with sequences from pSV2neo DNA, cotransfected as a selectable marker (S. Katzav, D. Martin-Zanca, and M. Barbacid, EMBO J. 8:2283-2290, 1989). The vav proto-oncogene is normally expressed in cells of hematopoietic origin. To determine whether the 5' rearrangement of vav or its ectopic expression in NIH 3T3 cells contributes to its transforming potential, we isolated murine and human proto-vav cDNA clones as well as human genomic clones corresponding to the 5' end of the gene. Normal proto-vav was poorly transforming in NIH 3T3 cells, whereas truncation of its 5' end greatly enhanced its transforming activity. The relative failure of full-length proto-vav cDNA clones to transform NIH 3T3 cells indicates that the transforming activity of vav is not simply due to ectopic expression. Analysis of the predicted amino terminus of the vav proto-oncogene shows that it contains a helix-loop-helix domain and a leucine zipper motif similar to that of myc family proteins, though it lacks a basic region that is usually found adjacent to helix-loop-helix domains. Loss of the helix-loop-helix domain of proto-vav, either by truncation or by rearrangement with pSV2neo sequences, activates its oncogenic potential.

This article has been cited by other articles:

• Hayakawa, M., Matsushima, M., Hagiwara, H., Oshima, T., Fujino, T., Ando, K., Kikugawa, K., Tanaka, H., Miyazawa, K., Kitagawa, M. (2008). Novel insights into FGD3, a putative GEF for Cdc42, that undergoes SCF(FWD1/beta-TrCP)-mediated proteasomal degradation analogous to that of its homologue FGD1 but regulates cell morphology and motility differently from FGD1.. GENES CELLS 13: 329-342 [Abstract] [Full Text]  
• Gazit, R., Aker, M., Elboim, M., Achdout, H., Katz, G., Wolf, D. G., Katzav, S., Mandelboim, O. (2007). NK cytotoxicity mediated by CD16 but not by NKp30 is functional in Griscelli syndrome. Blood 109: 4306-4312 [Abstract] [Full Text]  
• Kamynina, E., Kauppinen, K., Duan, F., Muakkassa, N., Manor, D. (2007). Regulation of Proto-Oncogenic Dbl by Chaperone-Controlled, Ubiquitin-Mediated Degradation. Mol. Cell. Biol. 27: 1809-1822 [Abstract] [Full Text]  
• Schapira, V., Lazer, G., Katzav, S. (2006). Osteopontin Is an Oncogenic Vav1- but not Wild-type Vav1-Responsive Gene: Implications for Fibroblast Transformation.. Cancer Res. 66: 6183-6191 [Abstract] [Full Text]  
• Kawakatsu, T., Ogita, H., Fukuhara, T., Fukuyama, T., Minami, Y., Shimizu, K., Takai, Y. (2005). Vav2 as a Rac-GDP/GTP Exchange Factor Responsible for the Nectin-induced, c-Src- and Cdc42-mediated Activation of Rac. J. Biol. Chem. 280: 4940-4947 [Abstract] [Full Text]  
• Palmby, T. R., Abe, K., Karnoub, A. E., Der, C. J. (2004). Vav Transformation Requires Activation of Multiple GTPases and Regulation of Gene Expression. Mol Cancer Res 2: 702-711 [Abstract] [Full Text]  
• Shin, E.-Y., Woo, K.-N., Lee, C.-S., Koo, S.-H., Kim, Y. G., Kim, W.-J., Bae, C.-D., Chang, S.-I., Kim, E.-G. (2004). Basic Fibroblast Growth Factor Stimulates Activation of Rac1 through a p85 {beta}PIX Phosphorylation-dependent Pathway. J. Biol. Chem. 279: 1994-2004 [Abstract] [Full Text]  
• Gregg, D., Rauscher, F. M., Goldschmidt-Clermont, P. J. (2003). Rac regulates cardiovascular superoxide through diverse molecular interactions: more than a binary GTP switch. Am. J. Physiol. Cell Physiol. 285: C723-C734 [Abstract] [Full Text]  
• Piccolella, E., Spadaro, F., Ramoni, C., Marinari, B., Costanzo, A., Levrero, M., Thomson, L., Abraham, R. T., Tuosto, L. (2003). Vav-1 and the IKK{alpha} Subunit of I{kappa}B Kinase Functionally Associate to Induce NF-{kappa}B Activation in Response to CD28 Engagement. J. Immunol. 170: 2895-2903 [Abstract] [Full Text]  
• Groysman, M., Hornstein, I., Alcover, A., Katzav, S. (2002). Vav1 and Ly-GDI Two Regulators of Rho GTPases, Function Cooperatively as Signal Transducers in T Cell Antigen Receptor-induced Pathways. J. Biol. Chem. 277: 50121-50130 [Abstract] [Full Text]  
• Palmby, T. R., Abe, K., Der, C. J. (2002). Critical Role of the Pleckstrin Homology and Cysteine-rich Domains in Vav Signaling and Transforming Activity. J. Biol. Chem. 277: 39350-39359 [Abstract] [Full Text]  
• Schmidt, A., Hall, A. (2002). Guanine nucleotide exchange factors for Rho GTPases: turning on the switch. Genes Dev. 16: 1587-1609 [Full Text]  
• Sachdev, P., Zeng, L., Wang, L. H. (2002). Distinct Role of Phosphatidylinositol 3-Kinase and Rho Family GTPases in Vav3-induced Cell Transformation, Cell Motility, and Morphological Changes. J. Biol. Chem. 277: 17638-17648 [Abstract] [Full Text]  
• Booden, M. A., Campbell, S. L., Der, C. J. (2002). Critical but Distinct Roles for the Pleckstrin Homology and Cysteine-Rich Domains as Positive Modulators of Vav2 Signaling and Transformation. Mol. Cell. Biol. 22: 2487-2497 [Abstract] [Full Text]  
• Zeng, L., Sachdev, P., Yan, L., Chan, J. L., Trenkle, T., McClelland, M., Welsh, J., Wang, L.-H. (2000). Vav3 Mediates Receptor Protein Tyrosine Kinase Signaling, Regulates GTPase Activity, Modulates Cell Morphology, and Induces Cell Transformation. Mol. Cell. Biol. 20: 9212-9224 [Abstract] [Full Text]  
• Moores, S. L., Selfors, L. M., Fredericks, J., Breit, T., Fujikawa, K., Alt, F. W., Brugge, J. S., Swat, W. (2000). Vav Family Proteins Couple to Diverse Cell Surface Receptors. Mol. Cell. Biol. 20: 6364-6373 [Abstract] [Full Text]  
• Billadeau, D. D., Mackie, S. M., Schoon, R. A., Leibson, P. J. (2000). The Rho Family Guanine Nucleotide Exchange Factor Vav-2 Regulates the Development of Cell-mediated Cytotoxicity. J. Exp. Med. 192: 381-392 [Abstract] [Full Text]  
• Billadeau, D. D., Mackie, S. M., Schoon, R. A., Leibson, P. J. (2000). Specific Subdomains of Vav Differentially Affect T Cell and NK Cell Activation. J. Immunol. 164: 3971-3981 [Abstract] [Full Text]  
• Abe, K., Rossman, K. L., Liu, B., Ritola, K. D., Chiang, D., Campbell, S. L., Burridge, K., Der, C. J. (2000). Vav2 Is an Activator of Cdc42, Rac1, and RhoA. J. Biol. Chem. 275: 10141-10149 [Abstract] [Full Text]  
• Bustelo, X. R. (2000). Regulatory and Signaling Properties of the Vav Family. Mol. Cell. Biol. 20: 1461-1477 [Full Text]  
• Landau, E., Tirosh, R., Pinson, A., Banai, S., Even-Ram, S., Maoz, M., Katzav, S., Bar-Shavit, R. (2000). Protection of Thrombin Receptor Expression under Hypoxia. J. Biol. Chem. 275: 2281-2287 [Abstract] [Full Text]  
• Kuhne, M. R., Ku, G., Weiss, A. (2000). A Guanine Nucleotide Exchange Factor-independent Function of Vav1 in Transcriptional Activation. J. Biol. Chem. 275: 2185-2190 [Abstract] [Full Text]  
• Abe, K., Whitehead, I. P., O'Bryan, J. P., Der, C. J. (1999). Involvement of NH2-terminal Sequences in the Negative Regulation of Vav Signaling and Transforming Activity. J. Biol. Chem. 274: 30410-30418 [Abstract] [Full Text]  
• Hu, Z.-Z., Zhuang, L., Meng, J., Dufau, M. L. (1998). Transcriptional Regulation of the Generic Promoter III of the Rat Prolactin Receptor Gene by C/EBPbeta and Sp1. J. Biol. Chem. 273: 26225-26235 [Abstract] [Full Text]  
• Billadeau, D. D., Brumbaugh, K. M., Dick, C. J., Schoon, R. A., Bustelo, X. R., Leibson, P. J. (1998). The Vav-Rac1 Pathway in Cytotoxic Lymphocytes Regulates the Generation of Cell-mediated Killing. J. Exp. Med. 188: 549-559 [Abstract] [Full Text]  
• Romero, F., Germani, A., Puvion, E., Camonis, J., Varin-Blank, N., Gisselbrecht, S., Fischer, S. (1998). Vav Binding to Heterogeneous Nuclear Ribonucleoprotein (hnRNP) C. EVIDENCE FOR Vav-hnRNP INTERACTIONS IN AN RNA-DEPENDENT MANNER. J. Biol. Chem. 273: 5923-5931 [Abstract] [Full Text]  
• Gringhuis, S. I., de Leij, L. F. M. H., Coffer, P. J., Vellenga, E. (1998). Signaling through CD5 Activates a Pathway Involving Phosphatidylinositol 3-Kinase, Vav, and Rac1 in Human Mature T Lymphocytes. Mol. Cell. Biol. 18: 1725-1735 [Abstract] [Full Text]  
• Ogilvy, S., Elefanty, A. G., Visvader, J., Bath, M. L., Harris, A. W., Adams, J. M. (1998). Transcriptional Regulation of vav, a Gene Expressed Throughout the Hematopoietic Compartment. Blood 91: 419-430 [Abstract] [Full Text]  
• Gimona, M, Mital, R (1998). The single CH domain of calponin is neither sufficient nor necessary for F-actin binding. J. Cell Sci. 111: 1813-1821 [Abstract]  
• Miyakawa, Y., Oda, A., Druker, B. J., Ozaki, K., Handa, M., Ohashi, H., Ikeda, Y. (1997). Thrombopoietin and Thrombin Induce Tyrosine Phosphorylation of Vav in Human Blood Platelets. Blood 89: 2789-2798 [Abstract] [Full Text]  
• Cohen, H. T., Bossone, S. A., Zhu, G., McDonald, G. A., Sukhatme, V. P. (1997). Sp1 Is a Critical Regulator of the Wilms' tumor-1 Gene. J. Biol. Chem. 272: 2901-2913 [Abstract] [Full Text]  
• Bonnefoy-Berard, N, Munshi, A, Yron, I, Wu, S, Collins, T., Deckert, M, Shalom- Barak, T, Giampa, L, Herbert, E, Hernandez, J, Meller, N, Couture, C, Altman, A (1996). Vav: function and regulation in hematopoietic cell signaling. Stem Cells 14: 250-268 [Abstract]  
• Kon-Kozlowski, M., Pani, G., Pawson, T., Siminovitch, K. A. (1996). The Tyrosine Phosphatase PTP1C Associates with Vav, Grb2, and mSos1 in Hematopoietic Cells. J. Biol. Chem. 271: 3856-3862 [Abstract] [Full Text]  
• McKenney, D. W., Onodera, H., Gorman, L., Mimura, T., Rothstein, D. M. (1995). Distinct Isoforms of the CD45 Protein-tyrosine Phosphatase Differentially Regulate Interleukin 2 Secretion and Activation Signal Pathways Involving Vav in T Cells. J. Biol. Chem. 270: 24949-24954 [Abstract] [Full Text]  
• Clevenger, C. V., Ngo, W., Sokol, D. L., Luger, S. M., Gewirtz, , A. M. (1995). Vav Is Necessary for Prolactin-stimulated Proliferation and Is Translocated into the Nucleus of a T-cell Line. J. Biol. Chem. 270: 13246-13253 [Abstract] [Full Text]  
• Uddin, S., Katzav, S., White, M. F. (1995). Insulin-dependent Tyrosine Phosphorylation of the vav Proto-oncogene Product in Cells of Hematopoietic Origin. J. Biol. Chem. 270: 7712-7716 [Abstract] [Full Text]  
• Gulbins, E, Coggeshall, K., Baier, G, Katzav, S, Burn, P, Altman, A (1993). Tyrosine kinase-stimulated guanine nucleotide exchange activity of Vav in T cell activation. Science 260: 822-825 [Abstract]  
• Bustelo, X. R., Barbacid, M. (1992). Tyrosine Phosphorylation of the vav Proto-Oncogene Product in Activated B Cells. Science 256: 1196-1199 [Abstract]